Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?;Contraception hormonale et risque thromboembolique veineux : quand demander une étude de l'hémostase ? Et laquelle ?

Gynecologie Obstetrique et Fertilite

Volumn 36, Issue 4, 2008, Pages 448-454

  Plu Bureau, G ^a,b   Horellou, M H ^c   Gompel, A ^a   Conard, J ^c  

^a HÔTEL DIEU   (France)

^b INSERM   (France)

^c Unité d'hémostase thrombose   (France)

Author keywords

Coagulation; Contraception; Venous thromboembolism risk

Indexed keywords

ETHINYLESTRADIOL; RALOXIFENE; TAMOXIFEN;

ARTICLE; BLOOD CLOTTING DISORDER; CARDIOVASCULAR RISK; FAMILY HISTORY; HEMOSTASIS; HEREDITY; HORMONAL CONTRACEPTION; HORMONE SUBSTITUTION; HUMAN; IMMOBILIZATION; LUNG EMBOLISM; MENOPAUSE; OBESITY; ORAL CONTRACEPTION; PREGNANCY; PRESCRIPTION; PUERPERIUM; THROMBOPHILIA; THROMBOSIS; TRAVEL; VARICOSIS; VENOUS THROMBOEMBOLISM;

EID: 43049103112     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2008.02.006     Document Type: Article

References (31)